Connections >> May 2013
23 May 2013
Connections is MSFHR's monthly e-newsletter. Each issue highlights the top MSFHR news from the past month and showcases the impact of research we've funded.
In this issue:
- Virtual platform, real impact: How InspireNet connects researchers and practitioners
- Feedback shaping next steps in health research strategy consultation
- Reduced HPV vaccine dosage effective
- Health research community helps shape BC's SPOR application
InspireNet, a province-wide network supported by MSFHR through the BC Nursing Research Initiative (BCNRI), was recently approved for a one-year funding extension through October 31, 2014.
The extension will help InspireNet sustain and enhance its ongoing work to build connections between researchers and practitioners through an online “virtual platform.” Since 2009, InspireNet has played an important role in engaging nurses, researchers, policy-makers, and students across BC in health services research. The network’s steadily growing membership now stands at more than 2,700.
InspireNet’s innovative model harnesses Web 2.0 technologies to bring like-minded individuals together. Research teams and health care practitioners working in one of BCNRI’s priority areas (see sidebar) can apply for an “electronic community of practice” (eCOP) to facilitate discussion and collaboration among team members.
Stakeholders in BC’s health research community are responding positively to opportunities to provide input into the development of a health research strategy for BC.
In late April, nearly 100 people participated in one of five focus sessions to offer their thoughts and feedback on the emerging directions. The insights gathered from these sessions have helped develop common themes that will shape the next steps in the consultation and, ultimately, the final strategy.
The planning team will be seeking feedback on a draft vision as part of the online survey, scheduled to launch on May 27.
A new MSFHR-supported study has found that two doses of a widely used human papillomavirus (HPV) vaccine may be just as effective as the standard three-dose regimen.
Over a three-year follow-up period, young girls vaccinated with two doses of the HPV vaccine Gardasil were found to have similar immune responses to those who received three doses. The study, published April 30 in the Journal of the American Medical Association, is based on research funded by MSFHR at the request of the provincial health officer to establish the most cost-effective way to achieve HPV immunity.
Consultation to inform BC's application to CIHR's Strategy for Patient-Oriented Research (SPOR) SUPPORT (Support for People and Patient-Oriented Research and Trials) Unit is ongoing. With the support of the Health Research Council of BC, focus sessions were held May 21 and 22 to seek input from members of the health research community who are potential users and providers of SPOR SUPPORT Unit services.
Based on feedback from these sessions, as well as ongoing engagement with health system leaders and patient advocates, MSFHR will issue a call for expressions of interest in developing a SUPPORT Unit business plan. An announcement will be issued when the launch date for expressions of interest has been determined. Check MSFHR's website for updates.
MSFHR is facilitating the development of British Columbia's SPOR SUPPORT Unit application. This unit is intended to be a regional centre of excellence that will stimulate and enhance the conduct of patient-oriented research.
- Dr. Martha MacLeod & Ms. Pat Porterfield
Two MSFHR-supported nursing researchers were recognized recently with Awards of Excellence by the College of Registered Nurses of British Columbia. Dr. Martha MacLeod (2005 Investigative Team Award; RAC member) was presented the Excellence in Nursing Research Award, and Pat Porterfield (2012 Knowledge Translation award team member) received the Award of Distinction.